REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoeconomic analysis, which structure and interpretatio...

Full description

Bibliographic Details
Main Authors: Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
Format: Article
Language:Russian
Published: IRBIS LLC 2015-09-01
Series:Фармакоэкономика
Subjects:
pharmacoeconomics
orphan drugs
rare diseases
cost-utility analysis
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/98

Internet

https://www.pharmacoeconomics.ru/jour/article/view/98

Similar Items